Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liquid biopsy in the clinical management of hepatocellular carcinoma
Johann von Felden, Teresa García‐Lezana, Kornelius Schulze, et al.
Gut (2020) Vol. 69, Iss. 11, pp. 2025-2034
Closed Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba, Scott L. Friedman, Gerald I. Shulman
Cell (2021) Vol. 184, Iss. 10, pp. 2537-2564
Open Access | Times Cited: 1292
Global Epidemiology and Genetics of Hepatocellular Carcinoma
Ming Ren Toh, Evelyn Wong, Sunny H. Wong, et al.
Gastroenterology (2023) Vol. 164, Iss. 5, pp. 766-782
Closed Access | Times Cited: 293
Molecular pathogenesis and systemic therapies for hepatocellular carcinoma
Josep M. Llovet, Roser Pinyol, Robin Kate Kelley, et al.
Nature Cancer (2022) Vol. 3, Iss. 4, pp. 386-401
Open Access | Times Cited: 286
Liquid Biopsies: Applications for Cancer Diagnosis and Monitoring
Ivana Martins, Ilda Patrícia Ribeiro, Joana Jorge, et al.
Genes (2021) Vol. 12, Iss. 3, pp. 349-349
Open Access | Times Cited: 151
A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook
Anna Kramvis, Kyong‐Mi Chang, Maura Dandri, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 11, pp. 727-745
Open Access | Times Cited: 117
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
Josep M. Llovet, Roser Pinyol, Mark Yarchoan, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 294-311
Closed Access | Times Cited: 110
Biomarkers for immunotherapy of hepatocellular carcinoma
Tim F. Greten, Augusto Villanueva, Firouzeh Korangy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 780-798
Closed Access | Times Cited: 99
Diagnostic potential of exosomal extracellular vesicles in oncology
Mickensone Andre, Allen Caobi, Jana S. Miles, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 25
Hepatocellular Carcinoma Incidence and Mortality in the USA by Sex, Age, and Race: A Nationwide Analysis of Two Decades
Yazan Abboud, Mohamed Ismail, Hamza Khan, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 19
Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma
Johann von Felden, Amanda J. Craig, Teresa García‐Lezana, et al.
Oncogene (2020) Vol. 40, Iss. 1, pp. 140-151
Closed Access | Times Cited: 104
Role of extracellular vesicles in liver diseases and their therapeutic potential
Enis Kostallari, Shantha Valainathan, Louise Biquard, et al.
Advanced Drug Delivery Reviews (2021) Vol. 175, pp. 113816-113816
Open Access | Times Cited: 60
Precision diagnosis of Hepatocellular Carcinoma
Zhenxiao Wang, Hanjiao Qin, Shui Liu, et al.
Chinese Medical Journal (2023)
Open Access | Times Cited: 27
Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments
Claudia Campani, Sandrine Imbeaud, Gabrielle Couchy, et al.
Gut (2024) Vol. 73, Iss. 11, pp. 1870-1882
Closed Access | Times Cited: 12
New techniques to identify the tissue of origin for cancer of unknown primary in the era of precision medicine: progress and challenges
Wenyuan Ma, Hui Wu, Yiran Chen, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 2
Open Access | Times Cited: 10
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Soo Young Hwang, Pojsakorn Danpanichkul, Vatche G. Agopian, et al.
Clinical and Molecular Hepatology (2024)
Open Access | Times Cited: 9
Recent advances in low‐background luminescent nanomaterials‐enhanced lateral flow assays for clinical diagnosis
Liangwen Hao, Jing Chen, Quanshuang Li, et al.
Deleted Journal (2025)
Open Access | Times Cited: 1
Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer
Johann von Felden, Teresa García‐Lezana, Navneet Dogra, et al.
Gut (2021) Vol. 71, Iss. 10, pp. 2069-2080
Open Access | Times Cited: 49
Systemic Therapy for Advanced Hepatocellular Carcinoma: Current Stand and Perspectives
Daniel M. Girardi, Lara P. Sousa, Thiago A Miranda, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1680-1680
Open Access | Times Cited: 17
Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Miguel Sogbe, I. Bilbao, Francesco P. Marchese, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 2, pp. 177-190
Open Access | Times Cited: 8
The Role of Liquid Biopsy in Hepatocellular Carcinoma Prognostication
Ismaïl Labgaa, Augusto Villanueva, Olivier Dormond, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 659-659
Open Access | Times Cited: 35
Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma
Betül Gök Yavuz, Elshad Hasanov, Sunyoung S. Lee, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 1195-1207
Open Access | Times Cited: 33
Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma
Jin-Cui Yang, Junjie Hu, Yixin Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 27
LncRNA THEMIS2‐211, a tumor‐originated circulating exosomal biomarker, promotes the growth and metastasis of hepatocellular carcinoma by functioning as a competing endogenous RNA
Jiyou Yao, Xuefeng Hua, Jiewei Shi, et al.
The FASEB Journal (2022) Vol. 36, Iss. 4
Closed Access | Times Cited: 26
Biomarkers for response to immunotherapy in hepatobiliary malignancies
Zhifei Lin, Lun‐Xiu Qin, Jinhong Chen
Hepatobiliary & pancreatic diseases international (2022) Vol. 21, Iss. 5, pp. 413-419
Closed Access | Times Cited: 23
Circulating Extracellular Vesicle-Derived microRNAs as Novel Diagnostic and Prognostic Biomarkers for Non-Viral-Related Hepatocellular Carcinoma
Bootsakorn Boonkaew, Nantawat Satthawiwat, Nutcha Pinjaroen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16043-16043
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top